Publication|Articles|February 2, 2026

Drug Topics Journal

  • Drug Topics January/February 2026
  • Volume 170
  • Issue 1

Pharmacists Serve as Safeguards Against Polypharmacy

Fact checked by: Cheney Gazzam Baltz
Listen
0:00 / 0:00

Key Takeaways

  • Pharmacists are essential in managing polypharmacy, conducting medication reconciliations, and identifying drug interactions to streamline therapy and reduce adverse events.
  • Pharmacogenomics allows pharmacists to personalize treatment for cardiometabolic diseases, using genetic insights to optimize drug efficacy and safety.
SHOW MORE

Pharmacists play a crucial role in managing polypharmacy, enhancing patient care through medication reconciliation and personalized therapy strategies.

As clinical medicine continues to advance, the ability to treat patients with multiple coexisting conditions has never been greater. However, with this opportunity comes a complex challenge: polypharmacy. For many patients, particularly our aging population, managing a regimen of 5 or more daily medications is a daunting reality.

Polypharmacy requires more than just careful dispensing; it demands rigorous clinical intervention. Pharmacists are the primary safeguard in this process, conducting essential medication reconciliations and identifying potential drug-drug interactions that might otherwise go unnoticed across multiple prescribers. Their expertise allows them to streamline therapy, reduce the risk of adverse drug events, and ensure that each medication aligns with the patient’s overall health goals. By simplifying complex regimens, pharmacists provide patients with the clarity and confidence needed to adhere to their treatments safely.

In the cover story, Keith Loria examines the crucial role of pharmacists in managing polypharmacy for patients with complex behavioral health issues and chronic conditions. Loria highlights how pharmacists leverage their unique visibility into total medication profiles to ensure that every prescription serves a clear, intentional purpose while minimizing treatment burden and medication errors. Finally, he examines the necessity of deeper clinical integration and provider status to empower pharmacists as essential partners in collaborative care teams.

Additionally, Samantha Frear, PharmD, and Jennifer D. Goldman, PharmD, CDCES, BC-ADM, FCCP, explore the transformative potential of pharmacogenomics in managing cardiometabolic diseases, the leading cause of global mortality. They examine how pharmacists are leveraging their medication expertise to move beyond one-size-fits-all prescribing, using Clinical Pharmacogenetics Implementation Consortium guidelines and genetic insights to personalize therapy with high-impact drugs such as clopidogrel, warfarin, and statins. By identifying genetic variants that dictate drug efficacy and safety, pharmacists are establishing themselves as essential specialists in precision medicine on the front lines of patient care.

Jade Ranger, PharmD, discusses the evolution of pharmacy from ancient herbalism to its modern role as a cornerstone of accessible and clinical care. She examines how pharmacists are bridging critical gaps in our strained health care system by expanding their clinical roles—providing everything from life-saving vaccinations to acute illness testing and contraceptive prescribing—while advocating for the official provider status that reflects their expertise as medication experts.

When pharmacists are empowered to manage polypharmacy and treatment of complex diseases, the results are measurable: fewer hospitalizations, reduced health care costs, and, most importantly, a higher quality of life for the patient. Pharmacists’ vigilance turns a potential burden of complexity into a manageable path toward long-term health.

Thank you for reading.

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.


Latest CME